Literature DB >> 27193695

Compared to femoral venous access, upper extremity right heart catheterization reduces time to ambulation: A single center experience.

Bernadette Speiser1, Katrina Pearson1, Hui Xie2, Adhir R Shroff1,2, Mladen I Vidovich1,2.   

Abstract

OBJECTIVES: To determine ambulation times after right heart catheterization (RHC) via upper extremity access compared to femoral venous access.
BACKGROUND: Transradial coronary angiography has been associated with shorter times to ambulation. We hypothesized that RHC from the upper extremity would be similarly associated with shorter ambulation times when compared to traditional femoral access.
METHODS: We performed a single-center retrospective analysis of 379 consecutive patients who underwent a variety of diagnostic and interventional left- and right-heart procedures through upper extremity and femoral access sites.
RESULTS: The time to ambulation for RHC through the arm veins versus the femoral vein was lower (42.6 min ± 14.2 vs. 175.0 min ± 65.0, P < 0.001). Fluoroscopy times (8.5 min ± 6.8 vs. 12.8 min ± 8.4, P < 0.001) and radiation doses (64.1 Gy cm-2  ± 60.0 vs. 108.5 Gy cm-2  ± 71.6, P < 0.001) were reduced in the radial compared to femoral group, respectively. In multivariate analyses, upper arm access (P < 0.0001), lower heparin dose (P = 0.032), inpatient status (P = 0.01), and concurrent PCI (P = 0.03) were associated with shorter times to ambulation.
CONCLUSIONS: Right heart catheterization from the upper extremity is strongly associated with shorter times to ambulation.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  right heart catheterization; time to ambulation; upper extremity access

Mesh:

Year:  2016        PMID: 27193695     DOI: 10.1002/ccd.26573

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  1 in total

1.  Single arm access venous sinus stenting (SAVeS) technique: Technical note.

Authors:  Alexander D Ramos; Sri Sundararajan; Alejandro Santillan; Justin T Schwarz; Athos Patsalides
Journal:  Interv Neuroradiol       Date:  2020-04-27       Impact factor: 1.610

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.